Quantitative assessment of the effect of uracil-DNA glycosylase on amplicon DNA degradation and RNA amplification in reverse transcription-PCR
© Kleiboeker; licensee BioMed Central Ltd. 2005
Received: 02 March 2005
Accepted: 11 April 2005
Published: 11 April 2005
Although PCR and RT-PCR provided a valuable approach for detection of pathogens, the high level of sensitivity of these assays also makes them prone to false positive results. In addition to cross-contamination with true positive samples, false positive results are also possible due to "carry-over" contamination of samples with amplicon DNA generated by previous reactions. To reduce this source of false positives, amplicon generated by reactions in which dUTP was substituted for dTTP can be degraded by uracil DNA glycosylase (UNG). UNG does not degrade RNA but will cleave contaminating uracil-containing DNA while leaving thymine-containing DNA intact. The availability of heat-labile UNG makes use of this approach feasible for RT-PCR. In this study, real-time RT-PCR was used to quantify UNG degradation of amplicon DNA and the effect of UNG on RNA detection. Using the manufacturers' recommended conditions, complete degradation of DNA was not observed for samples containing 250 copies of amplicon DNA. Doubling the UNG concentration resulted in degradation of the two lowest concentrations of DNA tested, but also resulted in an increase of 1.94 cycles in the CT for RNA detection. To improve DNA degradation while minimizing the effect on RNA detection, a series of time, temperature and enzyme concentrations were evaluated. Optimal conditions were found to be 0.25 U UNG per 25 μl reaction with a 20 min, 30°C incubation prior to RT-PCR. Under these conditions, high concentrations of amplicon DNA could be degraded while the CT for RNA detection was increased by 1.2 cycles.
Molecular techniques have provided a valuable approach for detection of pathogens in both human and veterinary medicine [1–5]. As with any diagnostic technique, quality control of individual steps is critical to ensure the accuracy of results. When performing diagnostic PCR or reverse transcription (RT)-PCR, elimination of false positive results is crucial to ensuring diagnostic accuracy. False positives can occur due to contamination at any point in sample preparation and amplification procedures . For example, cross-contamination between positive and negative samples may occur during sample collection, nucleic acid extraction, PCR or RT-PCR reaction assembly or during agarose gel electrophoresis analysis. In addition to contamination by positive samples, false positive results are also possible due to contamination of samples at any point in the protocol with DNA generated by previous positive amplification reactions. This source of contamination is of particular concern since a positive amplification reaction can generate in excess of 1011 molecules of product (amplicon) DNA per reaction. Given that ten or fewer DNA template molecules can generate a positive result by PCR or RT-PCR, even minute levels of amplicon contamination can result in false positive results. Furthermore, the inherent stability of DNA under a variety of environmental conditions could potentially lead to false positive results weeks or months after contamination of reagents or equipment with amplicon DNA.
Uracil-DNA glycosylase (UNG) is a DNA repair enzyme that will cleave uracil-containing DNA while leaving the natural, thymine-containing DNA unaffected [7, 8]. During PCR, deoxyuridine triphosphate (dUTP) can be substituted for deoxythymidine triphosphate (dTTP) in the synthesis of product DNA. Thus to reduce the frequency of false positive results due to amplicon contamination, one common recommendation [9–12] has been to substitute dUTP for dTTP as a source of nucleotides for the PCR reaction. Amplicon DNA that has incorporated dUTP can then be degraded with uracil-DNA glycosylase prior to subsequent amplification reactions, thus preventing these molecules from producing false positive results by acting as template. This approach to elimination of carry-over contamination has led several manufacturers of commercial PCR and RT-PCR reagents to substitute dUTP in the reaction mixture in place of dTTP and in the case of some manufacturers to include UNG as a standard reagent in kits. The success of this approach for elimination of contaminating amplicon DNA depends on the availability of a heat-labile UNG enzyme, the heat-inactivation of which prevents cleavage of product DNA amplified from the target template. The half-life of heat-labile UNG has been estimated to be 2 minutes at 40°C  thus making the use of this enzyme feasible for both PCR and RT-PCR applications since the reverse transcription step is commonly performed at 45 – 50°C for 30 min or longer.
Real-time RT-PCR utilizes fluorescence to detect the presence of amplification products as the reaction occurs. The cycle at which a positive reaction is first detectible, termed the cycle threshold (CT) is proportionate to the concentration of template in a sample. Real-time PCR and RT-PCR amplification products are typically much shorter (e.g. 75 – 150 bases in length) compared to those generated by standard PCR and RT-PCR assays. In addition to rapid quantification of template RNA, real-time PCR and RT-PCR offers significant advantages over standard PCR and RT-PCR for detection of DNA or RNA in terms of reduced sample handling, the time required for analysis and analytical sensitivity. However, most importantly real-time assays have reduced (though certainly not eliminated) the opportunities for false positive results due to cross-contamination of samples since real-time assays are conducted in a "closed-tube" system, in which the tubes are not opened after amplification is complete. Nonetheless, given the rigorous standards in place for both human and veterinary diagnostic laboratories and the significant consequences of false positive results, even laboratories using real-time methods may employ strategies such as UNG addition prior to RT-PCR to reduce the potential for false positive results.
While the use of UNG to eliminate amplicon contamination has been previously reported for RT-PCR assays [14, 15], the effect of UNG on quantitative assay sensitivity for RNA detection has not been investigated to date. Nor has a quantitative assessment of the concentrations of contaminating DNA that can be degraded prior to RT-PCR been performed. Real-time (quantitative) RT-PCR detection of Porcine arterivirus (family Arteriviridae, order Nidovirales) RNA was used for these assessments. This virus is an important pathogen of swine and is thus frequently the target of diagnostic investigation with RT-PCR representing the principal assay for pathogen detection in many laboratories. Some high-value swine herds are free of this virus thus making the report of false positive results particularly troublesome since depopulation is a common method used to eliminate this virus from a herd. In this study, it was demonstrated that heat-labile UNG had a concentration, temperature and time-dependent effect on quantitative RT-PCR sensitivity and DNA degradation. Conditions were optimized so that minimal effects on target RNA amplification sensitivity were observed while maximizing the ability to degrade carry-over amplicon DNA contamination in a sample.
Effect of UNG concentration on DNA degradation and RT-PCR amplification of RNA
Effect of UNG concentration and incubation temperature on DNA degradation and RNA detectiona
0.5 U UNG
1.0 U UNG
Mean CT increase for RNA
Mean CT increase for DNA
Effect of UNG concentration on DNA degradation and RNA detectiona
0.1 U UNG
0.25 U UNG
0.5 U UNG
1.0 U UNG
Mean CT increase for RNA
Mean CT increase for DNA
An UNG concentration-dependent effect was also observed for RNA detection by RT-PCR (Table 2). The lowest UNG concentration tested, 0.1 U per 25 μl reaction, increased the mean CT of RNA detection by 0.59 cycles, while the highest concentration of UNG tested, 1.0 U per 25 μl reaction, increased the mean CT of RNA detection by 1.90 cycles. Intermediate CT increases were observed with 0.25 and 0.5 U UNG per reaction. The increases in CT values for RNA detection following incubation with UNG correspond to 1.5 – 3.7-fold decreases in detectible RNA.
Effect of incubation temperature and time on DNA degradation and RT-PCR amplification of RNA
Effect of incubation temperature on DNA degradation and RNA detection in the presence of UNGa
Mean CT increase for RNA
Mean CT increase for DNA
Effect of incubation time on DNA degradation and RNA detection in the presence of UNGa
Mean CT increase for RNA
Mean CT increase for DNA
Simultaneous detection of RNA amplification and DNA degradation
Effect of UNG and incubation prior to RT-PCR on standard curves for RNA quantification
Detection of low viral RNA concentrations in reactions containing UNG
To determine if UNG addition and incubation prior to RT-PCR would result in false negative results under the conditions described, 96 replicate samples containing approximately 20 copies of viral RNA per replicate were amplified by RT-PCR. Of the 96 replicate samples tested, positive amplification (defined as CT < 40) was not detected in three samples that contained 0.25 units UNG and were incubated at 30°C for 30 min prior to RT-PCR (data not shown). Of 96 control reactions (i.e. no UNG added and no incubation prior to RT-PCR), amplification was detected in all but one of the replicates. The mean CT increase of samples containing UNG and incubated at 30°C for 30 min prior to RT-PCR was 1.56 cycles, a value in agreement with results shown above.
The techniques of PCR and RT-PCR offer several advantages when compared to traditional viral diagnostic techniques, especially in terms of analytical sensitivity and time for assay completion. Unfortunately the high level of sensitivity, which approaches the single molecule level, also makes this technique prone to false positive results. Amplicon generated by previous positives reactions in which dUTP was substituted for dTTP can be degraded by UNG and thus theoretically eliminated as a source of template that would cause false positives in PCR or RT-PCR. UNG degrades contaminating uracil-containing DNA while leaving the natural, thymine-containing DNA intact. The precise, reproducible quantification of real-time RT-PCR provides a rapid method to assess and optimize the use of UNG to eliminate or reduce the impact of amplicon DNA in RT-PCR as well as determine the effects of UNG on RNA detection. The manufacturers' recommendation for the use of heat-labile UNG include addition of 1 unit enzyme per 50 μl reaction followed by an incubation time of 10 min at 15 – 25°C. In this study, this enzyme concentration and the incubation conditions were not found to eliminate amplicon DNA, presumably due at least in part to the short length of amplicon DNA (114 bases). To consistently degrade approximately 500 copies of amplicon DNA, a two-fold increase in UNG concentration was necessary. However, this concentration of UNG resulted in a nearly two cycle increase to reach the threshold for RNA detection. These results are corroborated by a recent publication using real-time PCR for detection of single-copy genes in which it was concluded that manufacturers' recommended conditions were not adequate to consistently degrade even minimal (e.g. < 30 copies) amounts of amplicon DNA .
To determine optimal conditions for amplicon degradation with minimal effect on RNA detection by RT-PCR, a series of time, temperature and enzyme concentrations were evaluated. From these results, it was shown that UNG degradation of amplicon DNA in RT-PCR was concentration, time and temperature depended, as previously described for real-time PCR . To allow degradation of considerable concentrations of carry-over amplicon DNA while having minimal effects on RNA detection, the optimal concentration of UNG was found to be 0.25 U per 25 μl reaction with a pre-amplification incubation at 30°C for 20 min. This incubation was performed after the complete reaction had been assembled in the reaction tubes, just prior to the RT step. These conditions completely degraded approximately 2,500 copies of carry-over amplicon DNA while reducing the detectible concentration of viral RNA template by 2.2-fold (i.e. CT values increased by a mean of 1.2 cycles). If higher levels of carry-over contamination are encountered, increasing the incubation time by an additional 10 min demonstrated degradation of a 10-fold higher concentration of amplicon DNA while only slightly increasing the CT for RNA detection. It is interesting to note that, based on analysis of the standard curves, increases observed in the CT for RNA were due both to the presence of UNG and the incubation at 30°C prior to RT-PCR.
Given the relatively long time required for the reverse transcriptase step, a heat-labile UNG that is rapidly and effectively inactivated at temperatures below that of the RT step must be used for this approach to be applied to control false positive reactions in RT-PCR. The commercially available heat-labile UNG used in this study is rapidly inactivated at 40°C with a half-life of 2 min . At the end of the UNG incubation, the samples were held at 55°C to rapidly inactivate UNG just prior to the RT step which was 50°C for 30 min. For the RT-PCR reagents used (as well as many other commercially availably RT-PCR reagents), the manufacture states that the 30 min RT step can be performed at temperatures of up to 55°C (or higher for some reagent systems), and reactions analyzed in preliminary experiments (data not shown) demonstrated no effect on RT-PCR analytical sensitivity following a 2 min incubation at 55°C prior to the RT step.
Results presented herein demonstrated that incubation with UNG appears to increase the CT equally for in vitro transcribed RNA and viral RNA, thus quantification through the use of a standard curve can remain accurate provided that all reactions are performed under the same conditions. However, a small percentage of weak positive samples may not be detected due to an increase in CT caused by UNG and incubation prior to RT-PCR. To the reduce the possibility of false negatives with dilute RNA samples, results from this study suggest that replicates of two or more reactions should be sufficient, given that the false negative rate was only increased by 2% for samples containing UNG and incubated prior to RT-PCR. Also, two – five additional cycles of amplification may provide positive amplification of target RNA in samples with very low concentrations.
Quantitative assessment of the effect of UNG on DNA degradation and RNA amplification over a range of enzyme concentrations, temperatures and times demonstrated that optimization of reaction conditions allows selection of conditions that maximize carry-over amplicon degradation while minimizing the effect on RNA detection. While this study was performed with real-time RT-PCR to provide accurate quantification of the effects of UNG, these findings are potentially useful to both standard and real-time RT-PCR amplification methods.
Quantitative (TaqMan) RT-PCR
Amplification reactions were performed using the Qiagen QuantiTect Probe RT-PCR kit (Qiagen, Inc., Valencia, CA) with thermocycling and detection performed in a Stratagene Mx4000 real-time PCR machine (Stratagene, Inc., La Jolla, CA). Samples were analyzed in triplicate. The amplification protocol, oligonucleotide primers and dual-labeled probe used for 5' exonuclease (TaqMan) amplification of the North American PRRSV Ingelvac MLV were as previously described  and amplified a 114-bp fragment. The amplified in the presence of dUTP, the sense strand and anti-sense strand will contain 36 and 26 uracil residues, respectively. The dual-labeled probe used for detection of heterologous competitor RNA (and amplicon DNA derived from the competitor RNA) was: 5'-HEX-TGTGCTGCAAGGCGATTAAGTTGGGT-BHQ2-3'. All oligonucleotide primers and dual-labeled probes were synthesized by Integrated DNA Technologies, Inc. (Coralville, IA). Negative control reactions, in which RNA extracted from normal (unaffected) swine tissues or serum was added as template to the RT-PCR reaction mixture, did not produce a signal for the quantitative RT-PCR assay.
Preparation of heterologous competitor RNA
Specific oligonucleotide primer binding sites for the PRRSV real-time RT-PCR assay were incorporated as 5' extensions in PCR primers and in vitro transcribed heterologous competitor RNA was prepared and spectrophotometrically quantified using methods previously described .
Viral RNA extraction
Extraction of Porcine arterivirus RNA from cell culture stocks of the vaccine strain Ingelvac MLV (derived by serial passage of U.S. prototype strain VR-2332) was performed using the Qiagen viral RNA kit (Qiagen, Inc., Valencia, CA) according to the manufacturer's instructions. Viral stocks were prepared in MARC-145 cells maintained in Dulbecco's Modified Eagle medium supplemented with 10% heat-inactivated fetal bovine serum and 2 mM L-glutamine, 0.25 μg/ml fungizone, and 0.5 mg/ml gentamycin (all supplied by Mediatech, Inc., Herndon, VA). The viral-infected cell cultures were maintained at 37°C in a humidified 5% CO2 incubator for approximately 2 days until viral cytopathic effect was readily identified throughout the culture. Extraction of heterologous competitor RNA after in vitro transcription was performed using the Qiagen RNeasy kit (Qiagen, Inc., Valencia, CA).
UNG treatment of reactions prior to RT-PCR
The indicated concentrations of heat-labile uracil-DNA glycosylase (Roche Applied Science, Indianapolis, IN), purified from the psychrophilic marine organism BMTU 3346  were added to the amplification master mix prior to dispensing into individual amplification tubes. Samples were then held in the thermocycler at the indicated temperatures for the indicated times prior to RT-PCR. At the end of the incubation, the thermocycler was programmed to ramp the samples at the maximum rate (2.2°C/sec) to 55°C and hold at this temperature for 5 min prior to the 50°C, 30 min RT step. Control reactions, which did not contain UNG and were not subjected to incubation prior to RT-PCR, were placed in the thermocycler at the beginning of the 55°C phase, prior to the 50°C, 30 min RT step.
The author wishes to thank Sunny J. Troxell for dedicated and expert technical contributions.
- Wagar EA: Direct hybridization and amplification applications for the diagnosis of infectious diseases. J Clin Lab Anal 1996, 10: 312-325. PublisherFullText 10.1002/(SICI)1098-2825(1996)10:6<312::AID-JCLA2>3.0.CO;2-8View ArticlePubMed
- Elnifro EM, Ashshi AM, Cooper RJ, Klapper PE: Multiplex PCR: optimization and application in diagnostic virology. Clin Microbiol Rev 2000, 13: 559-570. 10.1128/CMR.13.4.559-570.2000PubMed CentralView ArticlePubMed
- Sellon RK: Update on molecular techniques for diagnostic testing of infectious disease. Vet Clin North Am Small Anim Pract 2003, 33: 677-693.View ArticlePubMed
- Ivnitski D, O'Neil DJ, Gattuso A, Schlicht R, Calidonna M, Fisher R: Nucleic acid approaches for detection and identification of biological warfare and infectious disease agents. Biotechniques 2003, 35: 862-869.PubMed
- Yang S, Rothman RE: PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis 2004, 4: 337-348. 10.1016/S1473-3099(04)01044-8View ArticlePubMed
- Borst A, Box AT, Fluit AC: False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis 2004, 23: 289-299. 10.1007/s10096-004-1100-1View ArticlePubMed
- Kwok S, Hinguchi R: Avoiding false positives with PCR. Nature 1989, 339: 237-238. 10.1038/339237a0View ArticlePubMed
- Longo MC, Berninger MS, Hartley JL: Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990, 93: 125-128. 10.1016/0378-1119(90)90145-HView ArticlePubMed
- Pang J, Modlin J, Yolken R: Use of modified nucleotides and uracil-DNA glycosylase (UNG) for the control of contamination in the PCR-based amplification of RNA. Mol Cell Probes 1992, 6: 251-256. 10.1016/0890-8508(92)90024-RView ArticlePubMed
- Rys PN, Persing DH: Preventing false positives: quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products. J Clin Microbiol 1993, 31: 2356-2360.PubMed CentralPubMed
- Poddar SK, Sawyer MH, Connor JD: Optimized PCR amplification of influenza A virus RNA using Tth DNA polymerase, incorporating uracil N glycosylase (UNG) in a single tube reaction. J Clin Lab Anal 1997, 11: 323-327. 10.1002/(SICI)1098-2825(1997)11:6<323::AID-JCLA2>3.0.CO;2-6View ArticlePubMed
- Udaykumar , Epstein JS, Hewlett IK: A novel method employing UNG to avoid carry-over contamination in RNA-PCR. Nucleic Acids Res 1993, 21: 3917-3918.PubMed CentralView ArticlePubMed
- Sobek H, Schmidt M, Frey B, Kaluza K: Heat-labile uracil-DNA glycosylase: purification and characterization. FEBS Lett 1996, 388: 1-4. 10.1016/0014-5793(96)00444-9View ArticlePubMed
- Hofmann-Lehmann R, Swenerton RK, Liska V, Leutenegger CM, Lutz H, McClure HM, Ruprecht RM: Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum. Retroviruses 2000, 16: 1247-5127. 10.1089/08892220050117014View ArticlePubMed
- Taggart EW, Carroll KC, Byington CL, Crist GA, Hillyard DR: Use of heat labile UNG in an RT-PCR assay for enterovirus detection. J Virol Methods 2002, 105: 57-65. 10.1016/S0166-0934(02)00080-0View ArticlePubMed
- Pierce KE, Wangh LJ: Effectiveness and limitations of uracil-DNA glycosylases in sensitive real-time PCR assays. Biotechniques 2004, 36: 44-46. 48PubMed
- Kleiboeker SB, Schommer SK, Lee S-M, Watkins S, Chittick W, Polson D: Simultaneous detection of North American and European Porcine reproductive and respiratory syndrome virus using real-time quantitative RT-PCR. J Vet Diagn Invest 2005, 17: 165-170.View ArticlePubMed
- Kleiboeker SB: Applications of competitor RNA in diagnostic reverse transcription-PCR. J Clin Microbiol 2003, 41: 2055-2061. 10.1128/JCM.41.5.2055-2061.2003PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.